Synergy Pharmaceuticals – Creditors Committee Objects to Appointment of Independent Director and Retention of Kirkland as “Last Ditch” Effort to Protect Directors and Officers

March 5, 2019 – The Debtors’ Official Committee of Unsecured Creditors (the “Creditors Committee”) objected to the Debtors’ motion for (i) the appointment of an independent director (the “Investigation Motion”) and (ii) the retention of Kirkland & Ellis as counsel to the independent director [Docket No. 498]. The Debtors’ Official Committee of Equity Security Holders…